Objective: Cognitive deficits have been presented in the prior to the onset of other symptoms of schizophrenia and generally persisted during the course of the disease. Whether cognitive function is affects by antipsychotic treatment during the course of schizophrenia is still debated. This study aimed to examine the effect of long-term treatment of antipsychotic drugs on cognitive function in patients with chronic schizophrenia.
Methods: The study assessed cognitive function in 395 healthy controls and 438 patients with chronic schizophrenia on long-term treatments with antipsychotics, including mainly monotherapy with clozapine (n = 224), risperidone (n = 99) and typical antipsychotics (n = 115).
Results: Cognitive test scores were significantly lower in all patient groups than healthy controls on all scales (all p < 0.001) except for visuospitial/constructional index. Clozapine treatment had significantly lower immediate memory and delayed memory than typical antipsychotics (all p < 0.01). Clozapine treatment had better language index than risperidone (p < 0.01).
Conclusion: Patients with chronic schizophrenia performed significant cognitive deficits than healthy controls in all examined cognitive domains except for the visuospitial/constructional index. Cognitive deficits in patients with chronic schizophrenia were significantly influenced by different type's antipsychotics treatment. Clozapine treatment had worse immediate memory and delayed memory than typical antipsychotics, and better language performance than risperidone.
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